A foreign press reported that British scientists are expected to develop a universal vaccine that will block all coronavirus mutations within a year or so.
The Telegraph reported that researchers at the University of Nottingham are developing a vaccine that works against all mutant viruses by targeting the center of the coronavirus, not the dendritic protein.
The vaccine targets proteins in the core of the virus, which are much less mutagenic.
In the UK, cancer vaccine specialist Scancell is working with researchers at the University of Nottingham to develop a universal vaccine.
They plan to begin testing in humans in the second half of this year.
Several companies in Europe and the United States are also conducting related research.
The Telegraph pointed out that influenza is not an easy task, given that there is no vaccine to prevent all mutations.
"But the tests so far have shown positive results, so if the investment goes well, we can develop it in a year."